Skip to main content

Value-Based Care in Cardiometabolic Health August 2012, Vol 1, No 2

Real-Time Continuous Glucose Monitoring Cost-Effective in Patients with Type 2 Diabetes

Early Intensive Therapy in Type 2 Diabetes Preserves Beta-Cell Function

Quality Improvement Programs Enhance Diabetes Care, Especially When Baseline Measures Are Poor

TODAY Study: New Data, Implications for Young Patients with Diabetes

1 in 4 Patients with Type 2 Diabetes Does Not Take Basal Insulin as Prescribed

Achieving Normoglycemia, Even Once, Significantly Reduces Diabetes Risk in Patients with Prediabetes

Diabetes Drug Pipeline: Promising Agents in Late Stages of Development

Novel Risk Factors for Type 2 Diabetes

Empagliflozin Safe and Effective with or without Metformin, Reduces Weight

Ninety Years of Insulin: What’s Needed? What’s New?

Page 1 of 4
Results 1 - 10 of 34